Document Type

Article

Publication Date

11-2010

Abstract

Clinicians practicing today need to be aware of the ways in which the current industry-dominated climate may undermine the integrity of the scientific process and, thus, may compromise patient care. In the mental health field, corporate sponsorship bias can affect psychiatric taxonomy and clinical Practice Guidelines (CPG). Financial conflicts of interest (FCOI) can occur when there are financial associations between researchers, authors, or panel members developing psychiatric diagnostic and treatment guidelines, and the pharmaceutical industry, or when randomized clinical trials (RCTs) are industry funded. Therefore, clinicians need to be especially vigilant about the informed consent process when patients are prescribed psychotropic medications.

Comments

Published in THE TABLET: Newsletter of Division 55 of the American Psychological Association, Volume 11, Issue 3 (November 2010): http://www.division55.org/.

Cosgrove, 2010_Tablet.pdf (2605 kB)
Full issue (Volume 11, Issue 3) of THE TABLET: Newsletter of Division 55 of the American Psychological Association

Publisher

American Society for the Advancement of Pharmacotherapy, Division 55 of the American Psychological Association

Additional Files

Cosgrove, 2010_Tablet.pdf (2605 kB)

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.